Evidence map›Paper›PMID 34835263›Full record

ArticleVaccines2021

Investigating Adherence to COVID-19 Vaccination and Serum Antibody Concentration among Hospital Workers-The Experience of an Italian Private Hospital.

Guglielmo Forgeschi, Giuseppe Cavallo, Chiara Lorini, Fiamma Balboni, Francesca Sequi, Guglielmo Bonaccorsi

Abstract read
In one paragraph

Article in Vaccines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Guglielmo ForgeschiIstituto Fiorentino di Cura e Assistenza S.p.A. (IFCA), Via del Pergolino 4, 50139 Florence, Italy.
Giuseppe CavalloDepartment of Health Science, University of Florence, Viale GB Morgagni 48, 50134 Florence, Italy.ORCID 0000-0002-6171-5101
Chiara LoriniDepartment of Health Science, University of Florence, Viale GB Morgagni 48, 50134 Florence, Italy.ORCID 0000-0003-3170-1857
Fiamma BalboniIstituto Fiorentino di Cura e Assistenza S.p.A. (IFCA), Via del Pergolino 4, 50139 Florence, Italy.
Francesca SequiIstituto Fiorentino di Cura e Assistenza S.p.A. (IFCA), Via del Pergolino 4, 50139 Florence, Italy.
Guglielmo BonaccorsiDepartment of Health Science, University of Florence, Viale GB Morgagni 48, 50134 Florence, Italy.ORCID 0000-0002-5171-4308

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SARS-CoV-2 transmission has been high, especially among healthcare workers worldwide during the first wave. Vaccination is recognized as the most effective approach to combat the pandemic, but hesitation to get vaccinated represents an obstacle. Another important issue is the duration of protection after administration of the full vaccination cycle. Based on these premises, we conducted a study to evaluate vaccination adherence and the anti-S antibodies levels among hospital workers, from January to March, 2021. To assess adherence, an anonymous questionnaire was used. Anti-S antibody levels were obtained from the monitoring serological sample database. In total, 56.2% of the unvaccinated people did not report a previous infection from COVID-19. Among those who have not been vaccinated, 12.5% showed distrust against the vaccine, 8.3% stated to have received contraindications to the vaccination, and 6.3% did not report any choice. Analyzing anti-S antibody levels, only one person was found to have a value below the lower cut-off, two weeks, and three months after receiving their second dose. One was below the cut-off after two weeks, and then above the same cut-off after three months. The results of our survey should be seen as a stimulus to further sensitize hospital staff to the importance of vaccination and pay attention to anti-S antibody levels monitoring.

Indexed as

anti-S antibodiesCOVID-19SARS-CoV-2vaccine adherencevaccine hesitancy

Identifiers

PMID34835263
PMCPMC8625988

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.